 Ligand Pharmaceuticals Inc. NASDAQ:LGNDs share price traded up 5.2 during trading on Tuesday after Benchmark raised their price target on the stock from 135.00 to 155.00. Benchmark currently has a buy rating on the stock. Ligand Pharmaceuticals traded as high as 119.49 and last traded at 119.42, 198,400 shares changed hands during trading. A decline ... 